NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.6000
0.00 (0.00%)
Oct 9, 2026, 3:18 PM EST
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 57.84 million as of October 9, 2026. It is the 31,915th most valuable company in the world and the 910th biggest in Canada. Its market cap has decreased by 22.12% in one year.
Market Cap
57.84M
Enterprise Value
56.48M
Revenue
n/a
Global Rank
Country Rank
#910 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 57.84M, an increase of 72.74%. That is a compound annual growth rate of 13.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 57.84M | -3.36% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 68.74M |
| ME Therapeutics Holdings | 60.78M |
| BriaCell Therapeutics | 49.50M |
| Sernova Biotherapeutics | 45.32M |
| Sharp Therapeutics | 43.26M |
| Microbix Biosystems | 43.15M |
| MedMira | 42.10M |
| Medicenna Therapeutics | 41.54M |